Trial intelligence / Profile preview

Succinylcholine vs rocuronium for emergence agitation after direct laryngoscopy biopsy

IRCT20210714051888N1Phase 2Completed

Sponsor
Iran University of Medical Sciences
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in agitation comparing Succinylcholine with Rocuronium (2 arms). Primary endpoint: Rate of emergence agitation. Started Nov 2021; status: completed.

02

Drugs

succinylcholinerocuronium
03

Conditions

agitation

Beyond the preview

Go deeper on IRCT20210714051888N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210714051888N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call